Notice2021-14008
Healthcare Infection Control Practices Advisory Committee (HICPAC) Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 1, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Healthcare Infection Control Practices Advisory Committee (HICPAC). This virtual meeting is open to the public, limited only by audio and web conference lines (300 audio and web conference lines are available). Registration is required. To register for this web conference, please go to: www.cdc.gov/hicpac. All registered participants will receive the meeting link and instructions shortly before the meeting.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 124 (Thursday, July 1, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 124 (Thursday, July 1, 2021)]
[Notices]
[Page 35094]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-14008]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC) Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by audio and web conference lines (300 audio
and web conference lines are available). Registration is required. To
register for this web conference, please go to: <a href="http://www.cdc.gov/hicpac">www.cdc.gov/hicpac</a>. All
registered participants will receive the meeting link and instructions
shortly before the meeting.
DATES: The meeting will be held on August 19, 2021, from 12:00 p.m. to
2:00 p.m., EDT.
ADDRESSES: Please click the link below to join the webinar: <a href="https://cdc.zoomgov.com/j/1612908106?pwd=M0xTVWxmUTRtZXhuOVBzWmsybFZxZz09">https://cdc.zoomgov.com/j/1612908106?pwd=M0xTVWxmUTRtZXhuOVBzWmsybFZxZz09</a>.
Meeting ID: 161 290 8106
Passcode: yq!BLL44
Dial-in Lines:
+1-669-254-5252 (San Jose)
+1-646-828-7666 (New York)
Meeting ID: 161 290 8106
Telephone Passcode: 47632330.
FOR FURTHER INFORMATION CONTACT: Koo-Whang Chung, M.P.H., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton
Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027; Telephone: (404)
498-0730; Email: <a href="/cdn-cgi/l/email-protection#470f0e041706040724232469202831"><span class="__cf_email__" data-cfemail="7c34353f2c3d3f3c1f181f521b130a">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; the Isolation
Precautions Guideline Workgroup; and the Neonatal Intensive Care Unit
Workgroup. Agenda items are subject to change as priorities dictate.
Procedures for Public Comment: Time will be available for public
comment. Members of the public who wish to provide public comments
should plan to attend the public comment session at the start time
listed. Please note that the public comment period may end before the
time indicated, following the last call for comments.
Procedures for Written Comment: The public may submit written
comments in advance of the meeting. Comments should be submitted in
writing by email to the contact person listed above. The deadline for
receipt of written public comment is July 26, 2021. All requests must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-14008 Filed 6-30-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 1, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.